Table 3

Summary of high-risk features in patients with asymptomatic carotid artery stenosis

Microembolic detection38*
StudyIpsilateral strokes with embolic signalsWithout embolic signalsOR (95% CI)
ACES385/77 (6.5%)5/390 (1.3%)5.35 (1.51 to 18.94)
Abbott et al782/60 (3.3%)4/171 (2.3%)1.44 (0.26 to 8.07)
Molloy and Markus791/12 (8.3%)0/30 (0%)7.96 (0.30 to 209.7)
Orlandi et al803/6 (50.0%)0/15 (0%)31.00 (1.29 to 747.03)
Slebler et al811/8 (12.5%)1/56 (1.8%)7.86 (0.44 to 140.14)
Spence et al825/32 (15.6%)3/287 (1.0%)17.53 (3.97 to 77.38)
Total17/195 (8.7%)13/949 (1.4)6.63 (2.85 to 15.44)
Plaque echolucency43*
StudyIpsilateral strokes with echolucent plaqueWith echogenic plaqueRR (95% CI)
Grønholdt et al838/63 (12.7%)7/48 (14.6%)0.87 (0.34 to 2.23)
Mathiesen et al845/100 (5.0%)1/77 (1.3%)3.85 (0.46 to 32.28)
Nicolaides et al8528/409 (6.8%)21/677 (3.1%)2.23 (1.28 to 3.87)
O'Holleran et al8613/88 (14.8%)6/205 (2.9%)5.12 (2.01 to 13.04)
Polak et al8730/856 (3.5%)73/4030 (1.8%)1.96 (1.25 to 2.90
Silvestrini et al888/61 (13.1%)31/560 (5.5%)2.58 (1.13 to 5.89)
Topakian et al898/164 (4.9%)2/271 (0.7%)6.61 (1.42 to 30.75)
Total100/1741 (5.7%)141/5868 (2.4%)2.48 (1.90 to 3.22)
Progression of stenosis
StudyIpsilateral strokes with progressionWithout progressionRR (95% CI)
Conrad et al55*36/262 (13.7%)54/638 (8.5%)1.62 (1.09 to 2.41)
Kakkos et al5719/222 (8.6%)40/899 (4.5%)1.92 (1.14 to 3.25)
Total†55/484 (11.4%)94/1537 (6.1%)1.86 (1.35 to 2.55)
Reduced cerebrovascular reserve (CVR)
StudyIpsilateral strokes in
normal CVR
Impaired CVROR (95% CI)
Gur et al900/23 (0.0%)2/21 (9.5%)6.03 (0.27 to 133.11)
Silvestrini et al434/54 (7.4%)8/40 (20.0%)3.13 (0.87 to 11.24)
Kimiagar et al910/14 (0.0%)6/21 (28.6%)12.16 (0.63 to 235.70)
Total†4/91 (4.4%)16/82 (19.5%)5.27 (1.68 to 16.51)
Intraplaque hemorrhage (IPH)
StudyIpsilateral strokes with
IPH
Without IPHHR (95% CI)
Schindler et al708/40 (20.0%) 2/96 (2.1%)14.5 (2.9 to 7.25)
Ipsilateral silent brain infarction (SBI)
StudyAnnual stroke rate with prior ipsilateral SBIWithout prior ipsilateral SBIHR (95% CI)
Kakkos et al543.6% 1.0% 3.0 (1.46 to 6.29)
  • *This study used ipsilateral neurologic symptom as outcome measure, including ipsilateral stroke, transient ischemic attack, or amaurosis fugax rather than solely ipsilateral strokes.

  • †Calculation derived from authors.

  • ‡The list of studies obtained these meta-analyses.38 43